The genomic characteristics of different progression patterns in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors

BACKGROUND: Fast progression (FP), hyperprogressive disease (HPD), and early death (ED) are the newly reported cancer progression patterns in response to immune checkpoint inhibitor (ICI) treatment. This study aimed to investigate the clinical and genomic characteristics of FP, HPD, and ED following...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingwen, Xiang, Chan, Wang, Yue, Zhou, Yan, Cao, Shuhui, Ling, Xuxinyi, Ye, Junyi, Zheng, Jingjing, Shao, Lin, Zhong, Hua, Han, Yuchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246171/
https://www.ncbi.nlm.nih.gov/pubmed/34268392
http://dx.doi.org/10.21037/atm-20-6910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246171/
https://www.ncbi.nlm.nih.gov/pubmed/34268392
http://dx.doi.org/10.21037/atm-20-6910

Ejemplares similares